Kevin Fischbeck
Stock Analyst at B of A Securities
(4.05)
# 527
Out of 4,905 analysts
171
Total ratings
67.21%
Success rate
5.52%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Downgrades: Underperform | $16 → $15 | $11.11 | +31.41% | 3 | Jul 16, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $27.95 | +7.33% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $168.94 | +9.51% | 15 | Jul 16, 2025 | |
| HCA HCA Healthcare | Downgrades: Neutral | $394 → $410 | $361.12 | +13.54% | 11 | Jul 16, 2025 | |
| HUM Humana | Maintains: Neutral | $320 → $260 | $220.41 | +17.96% | 15 | Jun 17, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $165 → $180 | $175.06 | +2.82% | 5 | May 14, 2025 | |
| UNH UnitedHealth Group | Downgrades: Neutral | $560 → $350 | $282.65 | +23.83% | 22 | May 14, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $21.92 | +103.01% | 6 | Feb 28, 2025 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $19.82 | +142.18% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $2.12 | +41.51% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $139 → $145 | $141.16 | +2.72% | 12 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $646 → $530 | $277.09 | +91.27% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $182.98 | +139.92% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.22 | -29.50% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $12.41 | -41.58% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $295.71 | +18.36% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $22.32 | +101.61% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $110.01 | -32.73% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.59 | +53.20% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $14.38 | +143.39% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.94 | +240.14% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $12.78 | -41.31% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $29.48 | -38.94% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $12.57 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $29.32 | -35.20% | 2 | Feb 9, 2018 |
Ardent Health
Jul 16, 2025
Downgrades: Underperform
Price Target: $16 → $15
Current: $11.11
Upside: +31.41%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $27.95
Upside: +7.33%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $168.94
Upside: +9.51%
HCA Healthcare
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $361.12
Upside: +13.54%
Humana
Jun 17, 2025
Maintains: Neutral
Price Target: $320 → $260
Current: $220.41
Upside: +17.96%
Tenet Healthcare
May 14, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $175.06
Upside: +2.82%
UnitedHealth Group
May 14, 2025
Downgrades: Neutral
Price Target: $560 → $350
Current: $282.65
Upside: +23.83%
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.92
Upside: +103.01%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $19.82
Upside: +142.18%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $2.12
Upside: +41.51%
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $141.16
Upside: +2.72%
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $277.09
Upside: +91.27%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $182.98
Upside: +139.92%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.22
Upside: -29.50%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $12.41
Upside: -41.58%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $295.71
Upside: +18.36%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $22.32
Upside: +101.61%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $110.01
Upside: -32.73%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.59
Upside: +53.20%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $14.38
Upside: +143.39%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.94
Upside: +240.14%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $12.78
Upside: -41.31%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $29.48
Upside: -38.94%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $12.57
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $29.32
Upside: -35.20%